{"id":12060,"date":"2026-09-11T14:26:21","date_gmt":"2026-09-11T14:26:21","guid":{"rendered":"https:\/\/www.musclestationth.com\/?p=12060"},"modified":"2026-09-11T14:26:21","modified_gmt":"2026-09-11T14:26:21","slug":"tesamorelin","status":"publish","type":"post","link":"https:\/\/www.musclestationth.com\/en\/tesamorelin\/","title":{"rendered":"Tesamorelin: EGRIFTA and its specific indication"},"content":{"rendered":"

Tesamorelin is a GHRH analogue with the US reference medicine EGRIFTA. Its product-specific indication must be distinguished from general fat-loss advertising and other vials sharing the substance name.<\/p>

What the research shows<\/h2>

The EGRIFTA WR label covers reduction of excess abdominal fat in adults with HIV-associated lipodystrophy and states it is not indicated for weight-loss management. It also distinguishes WR from SV, making formulation identity important. [1]<\/a><\/p>

Distinguishing substances and products<\/h2>

A tesamorelin label does not establish that a vial is EGRIFTA WR or SV. A US label does not verify Thai registration of another product; match the actual product and documentation.<\/p>

Reading a specific brand\u2019s label<\/h3>

Start with the exact substance and product name, then match the label to the manufacturer\u2019s documents. This article does not establish Thai registration or current availability for an unspecified product.<\/p>

Frequently asked questions<\/h2>

Is the labeled product a general weight-loss medicine?<\/h3>

No. EGRIFTA WR has a specific indication and is not indicated for general weight-loss management.<\/p>

Should WR and SV details be mixed?<\/h3>

No. The labeling distinguishes the formulations.<\/p>

What information helps identify a specific product?<\/h3>

The brand, product name, full label and matching manufacturer documents. Evidence about the substance alone does not establish a product\u2019s identity, registration or quality.<\/p>

Related information<\/h2>